Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.

Chaudhary P, Gibbs LD, Maji S, Lewis CM, Suzuki S, Vishwanatha JK.

Breast Cancer Res. 2020 Jan 28;22(1):11. doi: 10.1186/s13058-020-1251-8.

2.

ANXA2 expression in African American triple-negative breast cancer patients.

Gibbs LD, Chaudhary P, Mansheim K, Hare RJ, Mantsch RA, Vishwanatha JK.

Breast Cancer Res Treat. 2019 Feb;174(1):113-120. doi: 10.1007/s10549-018-5030-5. Epub 2018 Nov 26.

3.

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

Gibbs LD, Vishwanatha JK.

Oncotarget. 2017 Dec 23;9(2):2697-2704. doi: 10.18632/oncotarget.23627. eCollection 2018 Jan 5.

4.

Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis.

Maji S, Chaudhary P, Akopova I, Nguyen PM, Hare RJ, Gryczynski I, Vishwanatha JK.

Mol Cancer Res. 2017 Jan;15(1):93-105. doi: 10.1158/1541-7786.MCR-16-0163. Epub 2016 Oct 19.

5.

Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.

Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, Yan XD, Chen J.

World J Gastroenterol. 2012 Nov 7;18(41):5897-904. doi: 10.3748/wjg.v18.i41.5897.

6.
7.

Subcellular localization of total and activated Src kinase in African American and Caucasian breast cancer.

Anbalagan M, Moroz K, Ali A, Carrier L, Glodowski S, Rowan BG.

PLoS One. 2012;7(3):e33017. doi: 10.1371/journal.pone.0033017. Epub 2012 Mar 22.

8.

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.

Torres-Luquis O, Madden K, N'dri NM, Berg R, Olopade OF, Ngwa W, Abuidris D, Mittal S, Lyn-Cook B, Mohammed SI.

Breast Cancer (Dove Med Press). 2018 Dec 20;11:1-12. doi: 10.2147/BCTT.S185960. eCollection 2019.

9.
10.

CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.

Zhao C, Zheng S, Yan Z, Deng Z, Wang R, Zhang B.

Oncol Rep. 2020 Feb;43(2):571-580. doi: 10.3892/or.2019.7426. Epub 2019 Dec 11.

PMID:
31894281
11.

Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.

O'Meara T, Safonov A, Casadevall D, Qing T, Silber A, Killelea B, Hatzis C, Pusztai L.

Breast Cancer Res Treat. 2019 May;175(1):247-259. doi: 10.1007/s10549-019-05156-5. Epub 2019 Feb 6.

PMID:
30725384
12.

Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.

Newman LA, Stark A, Chitale D, Pepe M, Longton G, Worsham MJ, Nathanson SD, Miller P, Bensenhaver JM, Proctor E, Swain M, Patriotis C, Engstrom PF.

JAMA Oncol. 2017 Aug 1;3(8):1102-1106. doi: 10.1001/jamaoncol.2016.5598.

13.

ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer.

Zhang Y, Bi J, Zhu H, Shi M, Zeng X.

Biosci Biotechnol Biochem. 2018 Oct;82(10):1733-1741. doi: 10.1080/09168451.2018.1484275. Epub 2018 Jun 18.

PMID:
29912633
14.

Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.

Bystricky B, Cierna Z, Sieberova G, Janega P, Karaba M, Minarik G, Benca J, Sedlackova T, Jurisova S, Gronesova P, Pindak D, Macuch J, Mardiak J, Mego M.

Anticancer Res. 2017 May;37(5):2727-2734.

PMID:
28476852
15.

Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer.

Shetty P, Patil VS, Mohan R, D'souza LC, Bargale A, Patil BR, Dinesh US, Haridas V, Kulkarni SP.

Ann Clin Biochem. 2017 Jul;54(4):463-471. doi: 10.1177/0004563216665867. Epub 2016 Aug 5.

PMID:
27496793
16.

Kaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women.

Bassey-Archibong BI, Hercules SM, Rayner LGA, Skeete DHA, Smith Connell SP, Brain I, Daramola A, Banjo AAF, Byun JS, Gardner K, Dushoff J, Daniel JM.

Cancer Causes Control. 2017 Nov;28(11):1295-1304. doi: 10.1007/s10552-017-0955-2. Epub 2017 Sep 8.

17.

Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.

Zhang M, Zhang X, Zhao S, Wang Y, Di W, Zhao G, Yang M, Zhang Q.

Target Oncol. 2014 Dec;9(4):349-57.

PMID:
24233638
18.

Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.

Shetty PK, Thamake SI, Biswas S, Johansson SL, Vishwanatha JK.

PLoS One. 2012;7(9):e44299. doi: 10.1371/journal.pone.0044299. Epub 2012 Sep 5.

19.

Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.

Fan Y, Si W, Ji W, Wang Z, Gao Z, Tian R, Song W, Zhang H, Niu R, Zhang F.

Breast Cancer Res. 2019 May 22;21(1):66. doi: 10.1186/s13058-019-1147-7.

20.

Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.

Lindner R, Sullivan C, Offor O, Lezon-Geyda K, Halligan K, Fischbach N, Shah M, Bossuyt V, Schulz V, Tuck DP, Harris LN.

PLoS One. 2013 Nov 18;8(11):e71915. doi: 10.1371/journal.pone.0071915. eCollection 2013.

Supplemental Content

Support Center